Elevated expression of coactivator-associated arginine methyltransferase 1 is associated with early hepatocarcinogenesis
Open Access
- 2 August 2013
- journal article
- research article
- Published by Spandidos Publications in Oncology Reports
- Vol. 30 (4) , 1669-1674
Abstract
Aberrant expression of regulators for epigenetics is involved in tumorigenesis. There is an urgent need to identify and characterize regulators concerned with epigenetics in the early stages of hepatocarcinogenesis. In the present study, we found that the expression of coactivator-associated arginine methyltransferase 1 (CARM1), a histone methyltransferase that functions as a cofactor for nuclear hormone receptors and several transcription factors, was elevated in adenomas and aberrant in carcinomas during hepatocellular carcinogenesis. In addition to RNA expression, immunohistochemical staining of liver sections revealed that CARM1 was highly expressed in the nucleus of tumor marker glutathione S-transferase placental form (GST-P)-positive foci. Neoplastic transformation of GST-P-positive foci guides the formation of hepatocellular carcinomas. CARM1 expression was not elevated in GST-P-negative regions. Furthermore, a luciferase reporter analysis revealed that CARM1 activated the Gst-p promoter in H4IIE, a hepatocellular carcinoma cell line. This activation was mediated by the enhancer element responsible for the carcinogenic-specific expression of Gst-p and nuclear factor E2-related factor 2. Knockdown of Carm1 by shRNA in H4IIE cells inhibited cell proliferation. These findings suggest that aberrantly expressed CARM1 in tumor marker-positive cells promotes tumorigenesis in the early stages of hepatocarcinogenesis.Keywords
This publication has 29 references indexed in Scilit:
- Cancer epigenetics reaches mainstream oncologyNature Medicine, 2011
- Histone Methyltransferase PR-Set7 and Histone Variant H2A.Z, Induced during Hepatocarcinogenesis, Repress the Promoter Activity of the Tumor Marker Gene and the Ras-Induced Colony Formation ActivityJournal of Health Science, 2011
- Epigenetic modifications as therapeutic targetsNature Biotechnology, 2010
- Promotion of Anchorage-independent Growth by Cytoplasmic and Nuclear Histone Deacetylase 9Journal of Health Science, 2010
- High mobility group box associated with cell proliferation appears to play an important role in hepatocellular carcinogenesis in rats and humansToxicology, 2009
- Histone acetyltransferase MOZ acts as a co-activator of Nrf2–MafK and induces tumour marker gene expression during hepatocarcinogenesisBiochemical Journal, 2007
- Altered gene expression of transcriptional regulatory factors in tumor marker-positive cells during chemically induced hepatocarcinogenesisToxicology Letters, 2006
- Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancerNature Genetics, 2005
- Specific differences in gene expression profile revealed by cDNA microarray analysis of glutathione S-transferase placental form (GST-P) immunohistochemically positive rat liver foci and surrounding tissueCarcinogenesis, 2003
- Trans-activation of glutathione transferase P gene during chemical hepatocarcinogenesis of the rat.Proceedings of the National Academy of Sciences, 1993